Back Login for AI Analysis

    APLS (STOCKS)

    Apellis Pharmaceuticals, Inc. Common Stock

    $40.840000
    +0.050000 (+0.12%)
    Prev close: $40.790000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Cedric Francois
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $5,219.94M
    Employees
    710
    P/E (TTM)
    236.60
    P/B (TTM)
    13.95
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    3
    Strong Buy
    9
    Buy
    15
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2025 (Q4)
    $-0.47 $-0.39 -0.0816 -21.01%
    Sep 2025 (Q3)
    $1.67 $1.21 +0.4608 +38.11%
    Jun 2025 (Q2)
    $-0.33 $-0.48 +0.1485 +31.03%
    Mar 2025 (Q1)
    $-0.74 $-0.37 -0.3725 -101.36%